BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a phase 3 trial for metastatic castration-resistant prostate cancer (mCRPC). | BioNTech and ...

The La Jolla-based research institute continues its founding principle of collaboration across multiple fields ...

Researchers at the Weill Institute for Cell and Molecular Biology have uncovered new evidence that two major types of gene-controlling DNA sequences, promoters and enhancers, operate with a shared ...

The FDA cleared a second arm for enrollment in the trial after one NSCLC patient demonstrated a complete response to the non-boosted therapy.

As of Friday, February 27, ImmunityBio, Inc.’s IBRX share price has dipped by 7.02%, which has investors questioning if this is right time to buy.

Advancing Research, Awareness, and Targeted Youth Advocacy for Women Diagnosed with Breast Cancer Before Age 40 DENVER, ...

The trials in breast, lung, and colorectal cancer, supported by ARPA-H, will focus on guiding decisions across different lines of therapy using serial biopsies and tumor profiling.

The emerging field of Cancer Neuroscience has revealed that the nervous system plays a pivotal role in cancer initiation, progression, and metastasis.

In a combined effort, researchers from the University of Lethbridge helped discover a critical function of a specific ribonucleic acid in the growth of cancer cells.

An autoimmune disorder that affects the thyroid gland, called autoimmune hypothyroidism (AIHT), is the most common autoimmune disease, yet it remains largely understudied. New research from scientists ...

A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...

A single exposure to a toxic fungicide during pregnancy can increase epigenetic disease risk for 20 subsequent generations.